Procode Raises $10M Series A for AI Medical Billing

Procode, an innovator in AI-driven revenue cycle management (RCM) for surgical practices, has successfully closed a $10 million Series A funding round. The investment was spearheaded by Health Velocity Capital, signaling strong confidence in Procode's mission to streamline medical billing and enhance financial outcomes for physicians.

This significant capital infusion arrives on the heels of Procode's strategic acquisition of The Auctus Group, a recognized leader in RCM services specifically for plastic surgeons and dermatologists. The company also recently published its inaugural peer-reviewed research in the esteemed journal Plastic & Reconstructive Surgery (PRS) Global Open, underscoring its commitment to evidence-based advancements in the field.

The newly acquired funds are earmarked for aggressive expansion. Procode plans to enhance its proprietary AI-powered RCM platform, pursue further strategic acquisitions to broaden its service offerings, and accelerate its market penetration across all surgical specialties. A key focus will be extending its reach into the complex billing requirements of ambulatory surgical centers (ASCs).

Founded in 2024, Procode addresses a critical pain point for surgeons in private practice: the administrative burden associated with billing and reimbursement. By leveraging artificial intelligence, the company aims to automate complex processes, reduce claim denials, and optimize revenue capture, thereby allowing medical professionals to dedicate more time to patient care. The RCM market itself is substantial, with projections indicating continued growth driven by increasing healthcare complexity and the demand for operational efficiency.

With this latest funding, Procode has now raised a total of $14 million in venture capital. The company currently supports over 350 providers in plastic surgery and dermatology, a client base largely inherited and expanded from its acquisition of The Auctus Group. This foundation positions Procode for rapid scaling as it integrates its advanced AI capabilities into a wider array of medical practices.

The integration of AI into RCM is a rapidly evolving trend within healthtech. Solutions like Procode's are crucial as healthcare providers face mounting pressure to improve financial performance while navigating intricate coding regulations and payer policies. The ability to accurately predict claim outcomes, automate coding, and manage patient accounts efficiently offers a distinct competitive advantage in today's challenging healthcare economy.

Health Velocity Capital's investment highlights the growing investor appetite for technology solutions that demonstrably improve healthcare operations and financial health. Procode's dual focus on cutting-edge AI technology and a deep understanding of surgical practice RCM requirements makes it a compelling player in this dynamic sector.